|
501 |
Public Perceptions of the Pharmaceutical Industry and Drug Safety
Enthalten in Drug safety Bd. 32, 30.12.2012, Nr. 10, date:10.2009: 805-810
|
|
|
|
502 |
Pyelonephritis in Pregnancy
Enthalten in Drugs Bd. 70, 19.9.2012, Nr. 13, date:9.2010: 1643-1655
|
|
|
|
503 |
QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation
Enthalten in American journal of cardiovascular drugs Bd. 11, 17.8.2012, Nr. 3, date:6.2011: 199-208
|
|
|
|
504 |
Quality Measures for Medication Continuity in Long-Term Care Facilities, Using a Structured Panel Process
Enthalten in Drugs & aging Bd. 29, 31.8.2012, Nr. 4, date:4.2012: 319-327
|
|
|
|
505 |
Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia
Enthalten in Clinical drug investigation Bd. 30, 28.8.2012, Nr. 5, date:5.2010: 289-300
|
|
|
|
506 |
Quality of Life in Glaucoma and Three Other Chronic Diseases
Enthalten in Drugs & aging Bd. 26, 11.9.2012, Nr. 11, date:11.2009: 933-950
|
|
|
|
507 |
Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 8, date:8.2011: 519-530
|
|
|
|
508 |
Quetiapine
Enthalten in PharmacoEconomics Bd. 30, 6.1.2012, Nr. 7, date:7.2012: 611-631
|
|
|
|
509 |
Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder
Enthalten in CNS drugs Bd. 26, 29.8.2012, Nr. 5, date:5.2012: 421-434
|
|
|
|
510 |
Randomized Controlled Trials of COX-2 Inhibitors
Enthalten in Drug safety Bd. 34, 20.11.2012, Nr. 9, date:9.2011: 783-792
|
|
Administration
